Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hamps BioBOM:544312 -2.17%12 Gross Margin % is 64.29% as of Mar. 2026, which is 7% above its 10-year median of 60.06. GuruFocus rates BOM:544312 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Hamps Bio ranks better than 70.75% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Hamps Bio's Gross Profit for the
six
months ended in Mar. 2026 was ₹28.82 Mil. Hamps Bio's Revenue for the
six
months ended in Mar. 2026 was ₹44.83 Mil. Therefore, Hamps Bio's Gross Margin % for the quarter that ended in Mar. 2026 was 64.29%.
The historical rank and industry rank for Hamps Bio's Gross Margin % or its related term are showing as below:
BOM:544312'
s Gross Margin % Range Over the Past 10 Years
Min: 51.93 Med: 60.06 Max: 70.02
Current: 62.66
During the past 5 years, the highestGross Margin % of Hamps Bio was 70.02%. The lowest was 51.93%. And the median was 60.06%.
BOM:544312's Gross Margin % is ranked better than 70.75% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.25
vs BOM:544312: 62.66
Hamps Bio had a gross margin of 64.29% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Hamps Bio was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Hamps Bio had a gross margin of 64.29% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Hamps Bio Gross Margin % Related Terms
Hamps Bio Gross Margin % Historical Data
* Premium members only.
The historical data trend for Hamps Bio's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Hamps Bio's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hamps Bio Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hamps Bio's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Hamps Bio's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Hamps Bio (BOM:544312) has a Gross Margin % of 64.29% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Hamps Bio and its competitors. This is near median its historical median of 60.06. Over the past decade, Hamps Bio's Gross Margin % has ranged from 51.93 to 70.02. According to the industry distribution chart, Hamps Bio ranks #184 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 29.3%.
Is Hamps Bio's Gross Margin % too high?
Hamps Bio's current Gross Margin % of 64.29% is near median its 10-year median of 60.06. Over the past 10 years, this metric has ranged from a low of 51.93 to a high of 70.02. The Healthcare Providers & Services industry median Gross Margin % is 40.25. Hamps Bio's value of 64.29% is 59.7% above this industry median. Based on the distribution chart, Hamps Bio ranks #184 out of 629 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Hamps Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Hamps Bio's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Hamps Bio ranks #184 out of 629 companies for Gross Margin %. This puts Hamps Bio in the upper half of its industry. The industry median Gross Margin % is 40.25. Hamps Bio's value of 64.29% is 59.7% above this benchmark. Historically, Hamps Bio's own Gross Margin % has ranged from 51.93 to 70.02 over the past decade. While the company's 10-year median is 60.06 vs. the industry median of 40.25, Hamps Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.25, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hamps Bio's current Gross Margin % of 64.29% is 59.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Hamps Bio and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hamps Bio's current Gross Margin % is 64.29%, which is near median its own 10-year median of 60.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamps Bio stock overvalued right now?
Hamps Bio (BOM:544312) has a current Gross Margin % of 64.29%. The current Gross Margin % is 64.29%, which is near median its 10-year median of 60.06 and 59.7% above the Healthcare Providers & Services industry median of 40.25. Hamps Bio's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Hamps Bio (BOM:544312), the current Gross Margin % is 64.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
12GF Score
Get the complete analysis for BOM:544312
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544312 has been successfully added to your 
